<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ophthalmology</journal-id><journal-title-group><journal-title xml:lang="ru">Офтальмология</journal-title><trans-title-group xml:lang="en"><trans-title>Ophthalmology in Russia</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1816-5095</issn><issn pub-type="epub">2500-0845</issn><publisher><publisher-name>Ophthalmology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18008/1816-5095-2024-4-809-816</article-id><article-id custom-type="elpub" pub-id-type="custom">ophthalmology-2511</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ЭКСПЕРИМЕНТАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ЕXPERIMENTAL STUDIES</subject></subj-group></article-categories><title-group><article-title>Профилактика фиброзных изменений в модели офтальмо-хирургической травмы при лечении глаукомы</article-title><trans-title-group xml:lang="en"><trans-title>Prevention of Fibrous Changes in the Model of Ophthalmosurgical Trauma in the Treatment of Glaucoma</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Никитин</surname><given-names>В. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Nikitin</surname><given-names>V. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Никитин Владимир Николаевич, кандидат медицинских наук, врач‑офтальмохирург II хирургического отделения</p><p>ул. Академика Бардина, 4а, Екатеринбург, 620149</p></bio><bio xml:lang="en"><p>Nikitin Vladimir N., PhD, ophthalmic surgeon of the II surgical department</p><p>A. Bardina St. 4A, Ekaterinburg, 620149</p></bio><email xlink:type="simple">Wladimir.dok@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Иванов</surname><given-names>Д. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Ivanov</surname><given-names>D. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Иванов Дмитрий Иванович, доктор медицинских наук, заведующий II хирургическим отделением, врач‑офтальмохирург</p><p>ул. Академика Бардина, 4а, Екатеринбург, 620149</p></bio><bio xml:lang="en"><p>Ivanov Dmitry I., MD, head of the II Surgical Department, Ophthalmic Surgeon</p><p>A. Bardina St. 4A, Ekaterinburg, 620149</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ободов</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Obodov</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ободов Андрей Викторович, врач‑офтальмохирург I хирургического отделения</p><p>ул. Академика Бардина, 4а, Екатеринбург, 620149</p></bio><bio xml:lang="en"><p>Obodov Andrey V., ophthalmic surgeon of the 1st surgical department</p><p>A. Bardina St. 4A, Ekaterinburg, 620149</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Трунов</surname><given-names>А. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Trunov</surname><given-names>A. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Трунов Александр Николаевич, заведующий научным отделом, доктор медицинских наук, профессор, член‑корреспондент Российской академии естественных наук</p><p>ул. Колхидская, 10, Новосибирск, 630071</p></bio><bio xml:lang="en"><p>Trunov Alexander N., head of the scientific department, MD, Professor, Corresponding Member of the Russian Academy of Natural Sciences</p><p>10, Kolkhidskaya str., Novosibirsk, Russia, 630096.</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>АО Екатеринбургский центр МНТК «Микрохирургия глаза»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Eye Microsurgery Ekaterinburg Center</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Новосибирский филиал ФГАУ НМИЦ «МНТК “Микрохирургия глаза” им. академика С. Н. Федорова» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Novosibirsk Branch of the S.N. Fyodorov Eye Microsurgery Federal State Institution</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>25</day><month>12</month><year>2024</year></pub-date><volume>21</volume><issue>4</issue><fpage>809</fpage><lpage>816</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Никитин В.Н., Иванов Д.И., Ободов А.В., Трунов А.Н., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Никитин В.Н., Иванов Д.И., Ободов А.В., Трунов А.Н.</copyright-holder><copyright-holder xml:lang="en">Nikitin V.N., Ivanov D.I., Obodov A.V., Trunov A.N.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.ophthalmojournal.com/opht/article/view/2511">https://www.ophthalmojournal.com/opht/article/view/2511</self-uri><abstract><p>Процесс фиброза в зоне вновь сформированных путей оттока при хирургическом лечении глаукомы приводит к снижению эффективности. На сегодняшний день применяются различные подходы с целью уменьшения послеоперационного рубцевания. В ряде случаев применение тех или иных методик, а также их комбинаций не приносит ожидаемого результата. Предлагается в эксперименте оценить антифибротический эффект аутотрансплантата жировой ткани. В данном исследовании рассмотрена экспериментальная модель профилактики фиброзных изменений при хирургической травме при лечении глаукомы.</p><sec><title>Цель</title><p>Цель: разработка модели и экспериментальное клинико-морфологическое обоснование антифибротического эффекта аутотрансплантации жировой ткани в зоне хирургической травмы при лечении глаукомы.</p></sec><sec><title>Материал и методы</title><p>Материал и методы. Исследования проведены на 10 глазах лабораторных животных (5 половозрелых кроликов). Животным выполняли операцию, по объему травматического воздействия соответствующую операции непроникающего типа. Выделены две группы: основная — 5 глаз (левый глаз животного), хирургическое лечение проводили с введением фракции жировой ткани в зону операции, группа сравнения — 5 глаз (правый глаз животного) без аутотрансплантации жировой ткани. Срок наблюдения составил 1 месяц. При биомикроскопии на 1, 3, 5, 7, 10, 15 и 30-й день после вмешательства оценивали характеристику зоны операции согласно Вюрцбургской клинико-морфологической классификации (WBCS). После выведения животных из эксперимента проводили гистологическое сравнение участков ткани зон операции.</p></sec><sec><title>Результаты</title><p>Результаты. Сравнение суммарного индекса Вюрцбургской клинико-морфологической классификации показывает, что начиная с 5-го дня после вмешательства наблюдалась выраженная отличительная динамика между исследуемыми группами. В группе с введением жировой ткани имелась минимальная васкуляризация зоны операции с сохранением исходной высоты и ширины сформированной подушки на всем протяжении наблюдения. Гистологическое сравнение подтверждало отсутствие признаков образования рубцовой соединительной ткани в зоне операции у кроликов с аутотрансплантацией жировой ткани, в то время как у тех же кроликов в здоровых глазах имелась выраженная тенденция к рубцеванию.</p></sec><sec><title>Выводы</title><p>Выводы. На экспериментальной модели представлена возможность аутотрансплантации жировой ткани в субтеноновое пространство при хирургическом лечении глаукомы. Подтвержден антифибротический эффект на основе полученных клиникоморфологических данных.</p></sec></abstract><trans-abstract xml:lang="en"><p>The process of fibrosis in the area of newly formed outflow tracts during surgical treatment of glaucoma leads to a decrease in efficiency. Today, various approaches are used to reduce postoperative scarring. In some cases, the use of certain methods, as well as their combinations, does not bring the expected result. It is proposed to evaluate the antifibrotic effect of adipose tissue autograft in an experiment. This study considers an experimental model for preventing fibrotic changes in surgical trauma during glaucoma treatment.</p><sec><title>Objective</title><p>Objective: Development of a model and experimental clinical and morphological substantiation of the antifibrotic effect of adipose tissue autografting in the area of surgical trauma during glaucoma treatment.</p></sec><sec><title>Material and methods</title><p>Material and methods. The studies were conducted on 10 eyes of laboratory animals (5 mature rabbits). The animals underwent surgery according to the volume of traumatic impact corresponding to non-penetrating surgery. Two groups were identified: the main group — 5 eyes (the left eye of the animal) surgically treated with the introduction of a fraction of adipose tissue into the surgical area, the comparison group — 5 eyes (the right eye of the animal) without autotransplantation of adipose tissue. The observation period was 1 month. During biomicroscopy on days 1, 3, 5, 7, 10, 15 and 30 after the intervention, the characteristics of the surgical area were assessed according to the Würzburg Clinical and Morphological Classification (WBCS). After the animals were withdrawn from the experiment, histological comparison of the tissue areas of the surgical areas was performed.</p></sec><sec><title>Results</title><p>Results. Comparison of the total index of the Würzburg Clinical and Morphological Classification shows that starting from the 5th day after the intervention, there is a clear distinctive dynamic between the study groups. In the group with the introduction of adipose tissue, there was minimal vascularization of the surgical area, with the original height and width of the formed cushion maintained throughout the observation period. Histological comparison confirms the absence of signs of formation of scar connective tissue in the area of operation in rabbits with autotransplantation of adipose tissue, while in the comparison group rabbits there is a pronounced tendency to scarring.</p></sec><sec><title>Conclusions</title><p>Conclusions. The experimental model demonstrates the possibility of autotransplantation of adipose tissue into the sub-Tenon space in surgical treatment of glaucoma. The justification for the antifibrotic effect is obtained based on the obtained clinical and morphological data.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>хирургическое лечение глаукомы</kwd><kwd>фиброз</kwd><kwd>аутотрансплантация жировой ткани</kwd></kwd-group><kwd-group xml:lang="en"><kwd>surgical treatment of glaucoma</kwd><kwd>fibrosis</kwd><kwd>autotransplantation of fat tissue</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Weinreb RN, GarwayHeath D, Leung Ch, Mederios F, Liebmann J: Диагностика первичной открытоугольной глаукомы. 10й Консенсус Всемирной глаукомной ассоциации. М.: Офтальмология; 2019. 190 с.</mixed-citation><mixed-citation xml:lang="en">Weinreb RN, GarwayHeath D, Leung Ch, Mederios F, Liebmann J: Diagnosis of primary openangle glaucoma. The 10th Consensus of the World Glaucoma Association. Moscow: Ophthalmology; 2019. 190 p. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Петров СЮ, Волжанин АВ. Синустрабекулэктомия: история, терминология, техника. Национальный журнал глаукома. 2017;16(2):82–91.</mixed-citation><mixed-citation xml:lang="en">Petrov SYu, Volzhanin AV. Sinustrabeculectomy: history, terminology, technique. National Journal of Glaucoma. 2017;16(2):82–91 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Егорова ЕА, Еричев ВП. Национальное руководство по глаукоме: для практикующих врачей. М.: ГЭОТАР-Медиа; 2019. 384 c. doi: 10.33029/9704-5442-8-GLA-2020-1-384.</mixed-citation><mixed-citation xml:lang="en">Egorova EA, Yerichev VP. National Glaucoma Guidelines: for medical practitioners. Moscow: GEOTARMedia; 2019. 384 p. (In Russ.). doi: 10.33029/9704-5442-8-GLA-2020-1-384.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Куроедов АВ, Абышева ЛД, Авдеев РВ. Уровни внутриглазного давления при различном местном гипотензивном лечении при первичной открытоугольной глаукоме (многоцентровое исследование). Офтальмология Восточная Европа. 2016;6(1):27–42.</mixed-citation><mixed-citation xml:lang="en">Kuroedov AV, Abysheva LD, Avdeev RV, Alexandrov AS, Basinsky AS, Blum EA. Intraocular pressure levelsin variouslocal hypotensive treatment for primary open angle glaucoma (multicenterstudy). Ophthalmology Eastern Europe. 2016;6(1):27– 42 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Авдеев РВ, Александров АС, Бакунина НА. Анализ вариантов гипотензивного лечения пациентов с первичной открытоугольной глаукомой по результатам многоцентрового исследования в клиниках шести стран. Медикобиологические проблемы жизнедеятельности. 2018;1(19):95–111.</mixed-citation><mixed-citation xml:lang="en">Avdeev RV, Alexandrov AS, Bakunina NA. Analysis of options for hypotensive treatment of patients with primary openangle glaucoma based on the results of a multicenter study in clinics in six countries. Medical and biological problems of vital activity. 2018;1(19):95–111.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Егорова ЭВ., Любимова ТС., Узунян ДГ., Иващенко ЕВ. Способ лазерного лечения первичной открытоугольной глаукомы после проведенной микроинвазивной непроникающей глубокой склерэктомии. Патент RU 2576811, 25.12.2014.</mixed-citation><mixed-citation xml:lang="en">Egorova EV, Lyubimova TS, Uzunyan DG, Ivashchenko EV. A method of laser treatment of primary openangle glaucoma after microinvasive nonpenetrating deep sclerectomy. Patent RU 2576811, 12.25.2014 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Козлова ЕЕ, Любимова ТС, Глаткова ЕВ. Способ лечения первичной открытоугольной глаукомы после операции непроникающей глубокой склерэктомии на глазах с узким углом передней камеры. Патент RU 2718319, 21.08.2019.</mixed-citation><mixed-citation xml:lang="en">Kozlova EE, Lyubimova TS, Glatkova EV. Method of treatment of primary open angle glaucoma after surgery of nonpenetrating deep sclerectomy in the eyes with a narrow angle of the anterior chamber. Patent RU 2718319, 08.21.2019 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Колпакова ОА, Фабрикантов ОЛ. Способ выбора параметров лазерного воздействия при лечении далекозашедшей и терминальной рефрактерной глаукомы. Патент RU 2707379, 27.09.2018.</mixed-citation><mixed-citation xml:lang="en">Kolpakova OA, Fabrikantov OL. A method for selecting the parameters of laser exposure in the treatment of advanced and terminal refractory glaucoma. Patent RU 2707379, 09.27.2018 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Беликова ЕИ, Швайликова ИЕ. Способ хирургического лечения первичной субкомпенсированной открытоугольной глаукомы с наличием токсикоаллергической реакции на гипотензивную терапию. Патент RU 2735065, 13.04.2020.</mixed-citation><mixed-citation xml:lang="en">Belikova EI, Shvailikova IE. A method ofsurgical treatment of primary subcompensated openangle glaucoma with the presence of a toxicallergic reaction to hypotensive therapy. Patent RU 2735065, 04.13.2020 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Шмырева ВФ, Петров СЮ, Макарова АС. Причины снижения отдаленной гипотензивной эффективности антиглаукоматозных операций и возможности ее повышения. Глаукома. 2010;2:43–49.</mixed-citation><mixed-citation xml:lang="en">Shmyreva VF, Petrov SYu, Makarova AS. The reasons for the decrease in the long term hypotensive effectiveness of antiglaucomatous operations and the possibility of its increase. Glaucoma. 2010;2:43–49 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Бабушкин АЭ. Трабекулэктомия: профилактика избыточного рубцевания (обзор литературы). Точка зрения. Восток-Запад. 2017;4:128–131.</mixed-citation><mixed-citation xml:lang="en">Babushkin AE. Trabeculectomy: prevention of excessive scarring (literature review). Point of view. EastWest. 2017;4:128–131 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Van Bergen T, Van de Velde S, Vandewalle E. Improving patient outcomes following glaucoma surgery: state of the art and future perspectives. Clinical Ophthalmology. 2014;8:857–867. doi: 10.2147/OPTH.S48745.</mixed-citation><mixed-citation xml:lang="en">Van Bergen T, Van de Velde S, Vandewalle E. Improving patient outcomes following glaucoma surgery: state of the art and future perspectives. Clinical Ophthalmology. 2014;8:857–867. doi: 10.2147/OPTH.S48745.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Masoumpour M, Nowroozzadeh M, Razeghinejad M. Current and Future Techniques in Wound Healing Modulation after Glaucoma Filtering Surgeries. Open Ophthalmol J. 2016;10:68–85. doi: 10.2174/1874364101610010068.</mixed-citation><mixed-citation xml:lang="en">Masoumpour M, Nowroozzadeh M, Razeghinejad M. Current and Future Techniques in Wound Healing Modulation after Glaucoma Filtering Surgeries. Open Ophthalmol J. 2016;10:68–85. doi: 10.2174/1874364101610010068.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Петров С.Ю. Современная концепция борьбы с избыточным рубцеванием после фистулизирующей антиглаукомной операции. Факторы риска и антиметаболические препараты. Офтальмология. 2017;14:5–11. doi: 10.18008/1816-5095-2017-1-5-11.</mixed-citation><mixed-citation xml:lang="en">Petrov S.Yu. The modern concept of combating excessive scarring after fistulizing antiglaucoma surgery. Risk factors and antimetabolic drugs. Ophthalmology. 2017;14:5–11 (In Russ.). doi: 10.18008/1816-5095-2017-1-5-11.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Trelford C, Denstedt T, Armstrong J. The Pro–Fibrotic Behavior of Human Tenon’s Capsule Fibroblasts in Medically Treated Glaucoma Patients. Clin Ophthalmol. 2020;14:1391–1402. doi: 10.2147/OPTH.S245915.</mixed-citation><mixed-citation xml:lang="en">Trelford C, Denstedt T, Armstrong J. The Pro–Fibrotic Behavior of Human Tenon’s Capsule Fibroblasts in Medically Treated Glaucoma Patients. Clin Ophthalmol. 2020;14:1391–1402. doi: 10.2147/OPTH.S245915.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Holló G. Wound Healing and Glaucoma Surgery: Modulating the Scarring Process with Conventional Antimetabolites and New Molecules. Glaucoma Surgery. 2017;59:80–89. doi: 10.1159/000458488.</mixed-citation><mixed-citation xml:lang="en">Holló G. Wound Healing and Glaucoma Surgery: Modulating the Scarring Process with Conventional Antimetabolites and New Molecules. Glaucoma Surgery. 2017;59:80–89. doi: 10.1159/000458488.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Бикбов ММ, Хуснитдинов ИИ. Анализ эффективности фистулизирующих операций с дренажом Глаутекс. РМЖ. Клиническая офтальмология. 2017;17(2):82–85.</mixed-citation><mixed-citation xml:lang="en">Bikbov MM, Khusnitdinov II. Analysis of the effectiveness of fistulizing operations with drainage of Glautex. breast cancer. Clinical ophthalmology. 2017;17(2):82–85 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Khaw P. Advances in glaucoma surgery: evolution of antimetabolite adjunctive therapy. J Glaucoma. 2001;10(5 Suppl 1):81–84. doi: 10.1097/0006119820011000100029.</mixed-citation><mixed-citation xml:lang="en">Khaw P. Advances in glaucoma surgery: evolution of antimetabolite adjunctive therapy. J Glaucoma. 2001;10(5 Suppl 1):81–84. doi: 10.1097/0006119820011000100029.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Balkin D, Samra S, Steinbacher D. 2014; Immediate fat grafting in primary cleft lip repair. J Plast Reconstr Aesthet Surg 2014;67(12):1644–1650. doi: 10.1016/j.bjps.2014.08.049. Epub 2014 Aug 27.</mixed-citation><mixed-citation xml:lang="en">Balkin D,  Samra S,  Steinbacher D.  2014; Immediate fat grafting in primary cleft lip repair.  J Plast Reconstr Aesthet Surg  2014;67(12):1644–1650. doi: 10.1016/j.bjps.2014.08.049. Epub 2014 Aug 27.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Bollero D, Pozza S, Gangemi EN, De Marchi A, Ganem J,AM, Faletti C, Stella M. Contrastenhanced ultrasonography evaluation after autologous fat grafting in scar revision. Il Giornale di chirurgia. 2014;35(11–12): 266–273.</mixed-citation><mixed-citation xml:lang="en">Bollero D, Pozza S, Gangemi EN, De Marchi A, Ganem J,AM, Faletti C, Stella M. Contrastenhanced ultrasonography evaluation after autologous fat grafting in scar revision. Il Giornale di chirurgia. 2014;35(11–12): 266–273.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Ribuffo D, Atzeni M, Guerra M. Treatment of irradiated expanders: protective lipofilling allows immediate prosthetic breast reconstruction in the setting of postoperative radiotherapy. Aesthetic Plast Surg. 2013;37(6):1146–1152.</mixed-citation><mixed-citation xml:lang="en">Ribuffo D, Atzeni M, Guerra M. Treatment of irradiated expanders: protective lipofilling allows immediate prosthetic breast reconstruction in the setting of postoperative radiotherapy. Aesthetic Plast Surg. 2013;37(6):1146–1152.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Zellner EG, Pfaff MJ, Steinbacher DM. Fat grafting in primary cleft lip repair. Plast Reconstr Surg. 2015;135(5):1449–1453. doi: 10.1097/PRS.0000000000001187.</mixed-citation><mixed-citation xml:lang="en">Zellner EG, Pfaff MJ, Steinbacher DM. Fat grafting in primary cleft lip repair. Plast Reconstr Surg. 2015;135(5):1449–1453. doi: 10.1097/PRS.0000000000001187.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Spiekman M, van Dongen J, Willemsen J, Hoppe D. The power of fat and its adipose derived stromal cells: emerging concepts for fibrotic scar treatment. Journal of tissue engineering and regenerative medicine. 2017;11:3220–3235. doi: 10.1002/term.2213.</mixed-citation><mixed-citation xml:lang="en">Spiekman M, van Dongen J, Willemsen J, Hoppe D. The power of fat and its adipose derived stromal cells: emerging concepts for fibrotic scar treatment. Journal of tissue engineering and regenerative medicine. 2017;11:3220–3235. doi: 10.1002/term.2213.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Mazini L, Rochette L, Admou B. Hopes and Limits of AdiposeDerived Stem Cells (ADSCs) and Mesenchymal Stem Cells (MSCs) in Wound Healing. International journal of molecular sciences. 2020;21(4):1306. doi: 10.3390/ijms21041306.</mixed-citation><mixed-citation xml:lang="en">Mazini L, Rochette L, Admou B. Hopes and Limits of AdiposeDerived Stem Cells (ADSCs) and Mesenchymal Stem Cells (MSCs) in Wound Healing. International journal of molecular sciences. 2020;21(4):1306. doi: 10.3390/ijms21041306.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Spiekman M, Francia DL, Mossel DM. Autologous Lipofilling Improves Clinical Outcome in Patients with Symptomatic Dermal Scars Through Induction of a Pro Regenerative Immune Response. Aesthetic surgery journal. 2022;42(4):244–256. doi: 10.1093/asj/sjab280.</mixed-citation><mixed-citation xml:lang="en">Spiekman M, Francia DL, Mossel DM. Autologous Lipofilling Improves Clinical Outcome in Patients with Symptomatic Dermal Scars Through Induction of a Pro Regenerative Immune Response. Aesthetic surgery journal. 2022;42(4):244–256. doi: 10.1093/asj/sjab280.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Cattaneo P, Mukherjee D, Spinozzi S Parallel lineagetracing studies establish fibroblasts as the prevailing in vivo adipocyte progenitor. Cell Rep. 2020;30:571–582. doi: 10.1016/j.celrep.2019.12.046.</mixed-citation><mixed-citation xml:lang="en">Cattaneo P, Mukherjee D, Spinozzi S Parallel lineagetracing studies establish fibroblasts as the prevailing in vivo adipocyte progenitor. Cell Rep. 2020;30:571–582. doi: 10.1016/j.celrep.2019.12.046.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Sowa Y, Kishida T, Louis F. Direct conversion of human fibroblasts into adipocytes using a novel small molecular compound: implications for regenerative therapy for adipose tissue defects. Cells. 2023;10(3):605. doi: 10.3390/cells10030605.</mixed-citation><mixed-citation xml:lang="en">Sowa Y, Kishida T, Louis F. Direct conversion of human fibroblasts into adipocytes using a novel small molecular compound: implications for regenerative therapy for adipose tissue defects. Cells. 2023;10(3):605. doi: 10.3390/cells10030605.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Plikus MV, GuerreroJuarez CF, Ito M. Regeneration of fat cells from myofibroblasts during wound healing. Sci (New York NY). 2017;355:748–752. doi: 10.1126/science.aai8792.</mixed-citation><mixed-citation xml:lang="en">Plikus MV, GuerreroJuarez CF, Ito M. Regeneration of fat cells from myofibroblasts during wound healing. Sci (New York NY). 2017;355:748–752. doi: 10.1126/science.aai8792.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
